TRPM4-specific blocking antibody attenuates reperfusion injury in a rat model of stroke

Reperfusion therapy is currently the gold standard treatment for acute ischemic stroke. However, reperfusion injuries such as oedema and haemorrhagic transformation largely limit the use of this potent treatment to a narrow time window. Recently, transient receptor potential melastatin 4 (TRPM4) cha...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Bo, Gao, Yahui, Wei, Shunhui, Low, See Wee, Ng, Gandi, Yu, Dejie, Tu, Tian Ming, Soong, Tuck Wah, Nilius, Bernd, Liao, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Ion Channels, Receptors and Transporters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892354/
https://www.ncbi.nlm.nih.gov/pubmed/31664513
http://dx.doi.org/10.1007/s00424-019-02326-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892354/
https://www.ncbi.nlm.nih.gov/pubmed/31664513
http://dx.doi.org/10.1007/s00424-019-02326-8

Ejemplares similares